JD Health International, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG5074A1004
HKD
48.96
0.32 (0.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.3 M

Shareholding (Jun 2025)

FII

0.01%

Held by 1 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

  • Poor long term growth as Operating profit has grown by an annual rate 12.09% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2

Risky -

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 182,447 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.85

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

2.87

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.11%
0%
-13.11%
6 Months
-26.6%
0%
-26.6%
1 Year
45.5%
0%
45.5%
2 Years
76.43%
0%
76.43%
3 Years
-16.16%
0%
-16.16%
4 Years
3.18%
0%
3.18%
5 Years
-57.2%
0%
-57.2%

JD Health International, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
25.17%
EBIT Growth (5y)
12.09%
EBIT to Interest (avg)
-5.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.93
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.16
EV to EBIT
-80977.40
EV to EBITDA
-95113.88
EV to Capital Employed
11.62
EV to Sales
9650.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.01%
ROE (Latest)
-0.00%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by JD Health International, Inc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.61% vs 8.84% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 90.34% vs 431.40% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "63,058.30",
          "val2": "59,150.50",
          "chgp": "6.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,493.60",
          "val2": "948.40",
          "chgp": "57.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.90",
          "val2": "10.50",
          "chgp": "-15.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,507.10",
          "val2": "2,367.90",
          "chgp": "90.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.00%",
          "val2": "11.80%",
          "chgp": "0.82%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
63,058.30
59,150.50
6.61%
Operating Profit (PBDIT) excl Other Income
1,493.60
948.40
57.49%
Interest
8.90
10.50
-15.24%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4,507.10
2,367.90
90.34%
Operating Profit Margin (Excl OI)
20.00%
11.80%
0.82%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 6.61% vs 8.84% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 90.34% vs 431.40% in Dec 2023

stock-summaryCompany CV
About JD Health International, Inc. stock-summary
stock-summary
JD Health International, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available